A Study of RC108-ADC in Subjects With Advanced Digestive System Malignant Tumor
Status:
Not yet recruiting
Trial end date:
2025-10-15
Target enrollment:
Participant gender:
Summary
A multi-center, open-label, study designed to evaluate the preliminary efficacy, safety and
pharmacokinetics of RC108 in patients with c-Me-positive advanced digestive system
malignancies.